Literature DB >> 22240145

Advanced glycation endproducts in horses with insulin-induced laminitis.

M A de Laat1, M T Kyaw-Tanner, M N Sillence, C M McGowan, C C Pollitt.   

Abstract

Advanced glycation endproducts (AGEs) have been implicated in the pathogenesis of cancer, inflammatory conditions and diabetic complications. An interaction of AGEs with their receptor (RAGE) results in increased release of pro-inflammatory cytokines and reactive oxygen species (ROS), causing damage to susceptible tissues. Laminitis, a debilitating foot condition of horses, occurs in association with endocrine dysfunction and the potential involvement of AGE and RAGE in the pathogenesis of the disease has not been previously investigated. Glucose transport in lamellar tissue is thought to be largely insulin-independent (GLUT-1), which may make the lamellae susceptible to protein glycosylation and oxidative stress during periods of increased glucose metabolism. Archived lamellar tissue from horses with insulin-induced laminitis (n=4), normal control horses (n=4) and horses in the developmental stages (6h, 12h and 24h) of the disease (n=12) was assessed for AGE accumulation and the presence of oxidative protein damage and cellular lipid peroxidation. The equine-specific RAGE gene was identified in lamellar tissue, sequenced and is now available on GenBank. Lamellar glucose transporter (GLUT-1 and GLUT-4) gene expression was assessed quantitatively with qRT-PCR in laminitic and control horses and horses in the mid-developmental time-point (24 h) of the disease. Significant AGE accumulation had occurred by the onset of insulin-induced laminitis (48 h) but not at earlier time-points, or in control horses. Evidence of oxidative stress was not found in any group. The equine-specific RAGE gene was not expressed differently in treated and control animals, nor was the insulin-dependent glucose transporter GLUT-4. However, the glucose transporter GLUT-1 was increased in lamellar tissue in the developmental stages of insulin-induced laminitis compared to control horses and the insulin-independent nature of the lamellae may facilitate AGE formation. However, due to the lack of AGE accumulation during disease development and a failure to detect an increase in ROS or upregulation of RAGE, it appears unlikely that oxidative stress and protein glycosylation play a central role in the pathogenesis of acute, insulin-induced laminitis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22240145     DOI: 10.1016/j.vetimm.2011.12.016

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  Effect of digital hypothermia on lamellar inflammatory signaling in the euglycemic hyperinsulinemic clamp laminitis model.

Authors:  Simon M Stokes; Teresa A Burns; Mauria R Watts; François-René Bertin; Darko Stefanovski; Carlos E Medina-Torres; James K Belknap; Andrew W van Eps
Journal:  J Vet Intern Med       Date:  2020-06-25       Impact factor: 3.333

2.  ECEIM consensus statement on equine metabolic syndrome.

Authors:  Andy E Durham; Nicholas Frank; Cathy M McGowan; Nicola J Menzies-Gow; Ellen Roelfsema; Ingrid Vervuert; Karsten Feige; Kerstin Fey
Journal:  J Vet Intern Med       Date:  2019-02-06       Impact factor: 3.333

3.  Concentration Dependent Influence of Lipopolysaccharides on Separation of Hoof Explants and Supernatant Lactic Acid Concentration in an Ex Vivo/In Vitro Laminitis Model.

Authors:  Nicole Reisinger; Simone Schaumberger; Veronika Nagl; Sabine Hessenberger; Gerd Schatzmayr
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

Review 4.  Expression and regulation of facilitative glucose transporters in equine insulin-sensitive tissue: from physiology to pathology.

Authors:  Véronique A Lacombe
Journal:  ISRN Vet Sci       Date:  2014-03-04

5.  Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart.

Authors:  Melody A de Laat; Kaylynn J Gruntmeir; Christopher C Pollitt; Catherine M McGowan; Martin N Sillence; Véronique A Lacombe
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-22       Impact factor: 5.555

6.  Combination of resveratrol and 5-azacytydine improves osteogenesis of metabolic syndrome mesenchymal stem cells.

Authors:  Krzysztof Marycz; Katarzyna Kornicka; Jennifer M Irwin-Houston; Christine Weiss
Journal:  J Cell Mol Med       Date:  2018-07-12       Impact factor: 5.310

Review 7.  Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs).

Authors:  Malgorzata Teodorowicz; Wouter H Hendriks; Harry J Wichers; Huub F J Savelkoul
Journal:  Front Immunol       Date:  2018-09-13       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.